ChiCTR2300070052 版本V1.1 版本创建时间2023/07/09 21:00:05 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300070052 

最近更新日期:

Date of Last Refreshed on:

2023-03-31 16:13:53 

注册时间:

Date of Registration:

2023-03-31 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

基于5E康复模式的护理方案对老年脑梗死患者机体功能和焦虑抑郁的影响:随机对照研究

Public title:

Effect of the nursing program based on 5E rehabilitation model on body function, anxiety and depression of older patients with cerebral infarction: A randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于5E康复模式的老年脑梗死患者早期护理千预方案的构建及效果评价

Scientific title:

Construction and effect evaluation of early nursing plan for elderly patients with cerebral infarction based on 5E rehabilitation model

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张金华 

研究负责人:

崔雪岩 

Applicant:

Jinhua Zhang 

Study leader:

Xueyan Cui 

申请注册联系人电话:

Applicant telephone:

13837328062

研究负责人电话:

Study leader's
telephone:

15090442320

申请注册联系人传真 :

Applicant Fax:

3029987

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zjh.warm@163.com

研究负责人电子邮件:

Study leader's E-mail:

qx_work@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

新乡医学院

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省新乡市红旗区金穗大道601号

研究负责人通讯地址:

河南省新乡市红旗区金穗大道601号

Applicant address:

601 Jinsui Avenue, Xinxiang City, Henan Province

Study leader's address:

601 Jinsui Avenue, Xinxiang City, Henan Province

申请注册联系人邮政编码:

Applicant postcode:

453003

研究负责人邮政编码:

Study leader's postcode:

453003

申请人所在单位:

新乡医学院

Applicant's institution:

Xinxiang Medical University

研究负责人所在单位:

新乡医学院

Affiliation of the Leader:

Xinxiang Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

XYLL-2020250

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新乡医学院伦理委员会

Name of the ethic committee:

Ethics Committee of Xinxiang Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-10-29 00:00:00

伦理委员会联系人:

刘喜文

Contact Name of the ethic committee:

Xiwen Liu

伦理委员会联系地址:

河南省新乡市红旗区金穗大道601号

Contact Address of the ethic committee:

Xinxiang Medical University, 601 Jinsui Avenue,Xinxiang City, Henan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新乡医学院

Primary sponsor:

Xinxiang Medical University

研究实施负责(组长)单位地址:

河南省新乡市红旗区金穗大道601号

Primary sponsor's address:

601 Jinsui Avenue, Xinxiang City, Henan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南省

市(区县):

新乡市

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院

具体地址:

河南省新乡市红旗区金穗大道601号

Institution
hospital:

Xinxiang Medical University

Address:

601 Jinsui Avenue, Xinxiang City, Henan Province

经费或物资来源:

新乡医学院

Source(s) of funding:

Xinxiang Medical University

研究疾病:

脑卒中  

Target disease:

Cerebral Stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

(1)构建以5E康复模式为框架的老年脑梗死患者早期康复护理方案并评价对患者的身心影响;(2)为临床护理人员提供了一个有效的选择,作为传统护理方案的补充,以更好地满足这一人群的需求。  

Objectives of Study:

1.To construct an early rehabilitation nursing plan for older patients with cerebral infarction based on the 5E rehabilitation model and evaluate the physical and mental impact on patients;2.It provides an effective choice for clinical nursing staff, as a supplement to the traditional nursing scheme, to better meet the needs of this group of people.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)符合《中国急性缺血性脑卒中诊治指南2014》的诊断标准;(2)年龄≥60岁者;(3)首次发病;(4)发病后出现偏瘫症状;(5)意识清楚;(6)知情同意并签署知情同意书。

Inclusion criteria

1.meeting the diagnostic criteria of "China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2014"; 2. age ≥ 60 years; 3. first onset; 4. hemiplegia symptoms after onset; 5. clear consciousness; 6. informed consent and signed informed consent.

排除标准:

(1)病情危重;(2)其他原因造成肢体功能障碍;(3)伴有重大疾病(心、肝、肾等脏器疾病);(4)正在参加其他临床试验;(5)不同意出院随访者。

Exclusion criteria:

1.critical illness; 2. limb dysfunction caused by other reasons; 3. accompanied by major diseases (heart, liver, kidney, and other organ diseases); 4. participating in other clinical trials; 5. disagreeing to discharge follower.

研究实施时间:

Study execute time:

From 2021-02-08 00:00:00 To 2022-11-08 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-05-02 00:00:00 To 2022-09-02 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

42

Group:

intervention group

Sample size:

干预措施:

以5E康复模式为框架的护理方案

干预措施代码:

Intervention:

Nursing programme based

Intervention code:

组别:

对照组

样本量:

42

Group:

control group

Sample size:

干预措施:

常规护理

干预措施代码:

Intervention:

routine nursing

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南 

市(区县):

新乡 

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院第一附属医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital University of Xinxiang Medical

Level of the institution:

测量指标:

Outcomes:

指标中文名:

肌力

指标类型:

主要指标

Outcome:

muscle strength

Type:

Primary indicator

测量时间点:

干预前、干预1个月、干预2个月

测量方法:

徒手肌力分级检查

Measure time point of outcome:

Before intervention、Intervention at 1 month、Intervention at 2 months

Measure method:

Manual Muscle Testing,MMT

指标中文名:

运动功能

指标类型:

主要指标

Outcome:

motor function

Type:

Primary indicator

测量时间点:

干预前、干预1个月、干预2个月

测量方法:

Brunnstrom运动功能评定量表

Measure time point of outcome:

Before intervention、Intervention at 1 month、Intervention at 2 months

Measure method:

Brunnstrom motor function evaluation scale

指标中文名:

日常生活能力

指标类型:

主要指标

Outcome:

daily mobility

Type:

Primary indicator

测量时间点:

干预前、干预1个月、干预2个月

测量方法:

改良Barthel评分量表

Measure time point of outcome:

Before intervention、Intervention at 1 month、Intervention at 2 months

Measure method:

Modified Barthel Index

指标中文名:

焦虑抑郁

指标类型:

次要指标

Outcome:

Anxiety and Depression

Type:

Secondary indicator

测量时间点:

干预前、干预1个月、干预2个月

测量方法:

医院焦虑抑郁量表

Measure time point of outcome:

Before intervention、Intervention at 1 month、Intervention at 2 months

Measure method:

Hospital Anxiety and Depression Scale,HADS

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

No

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 86 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

选取2021年5月~2022年9月在新乡医学院某附属医院神经内科A病区和B病区住院的老年脑梗死患者84例作为研究对象。

Randomization Procedure (please state who generates the random number sequence and by what method):

A total of 84 older patients with cerebral infarction who were hospitalized in Ward A and Ward B of the Neurology Department of an affiliated hospital of *** from May 2021 to September 2022 were selected as the research subjects.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

单盲实验

Blinding:

An patient-blind randomised clinnical trial

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台 http://www.medresman.org.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Clinical Trial Management Public Platform http://www.medresman.org.cn

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Not

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-03-31 16:13:44